Evidence map›Paper›PMID 16333031›Full record

ArticleJournal of the National Cancer Institute2005

Chronic stress and susceptibility to skin cancer.

Alison N Saul, Tatiana M Oberyszyn, Christine Daugherty, Donna Kusewitt, Susie Jones, Scott Jewell, William B Malarkey, Amy Lehman, Stanley Lemeshow, Firdaus S Dhabhar

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. The emerging role of T cells in depression.Frontiers in psychiatry · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Chronic stress-induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy response.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alison N SaulColleges of Medicine and Public Health, The Ohio State University, Columbus, OH, USA.
Tatiana M Oberyszyn
Christine Daugherty
Donna Kusewitt
Susie Jones
Scott Jewell
William B Malarkey
Amy Lehman
Stanley Lemeshow
Firdaus S Dhabhar
American Association of Colleges of Pharmacy · USThe Ohio State University · US

Funding

Stress &UV-induced Squamous Cell CarcinomaR01CA107498 · NCI · STANFORD UNIVERSITY · PI DHABHAR, FIRDAUS S · 2005 to 2010
$1.5M
Stress &Enhancement of Skin Immunity: Molecular MechaniR01AI048995 · NIAID · OHIO STATE UNIVERSITY · PI QUAN, NING · 2001 to 2004
$1.2M
NCI NIH HHS CA107498NCI NIH HHS R01 CA107498NIAID NIH HHS AI 48995NIAID NIH HHS R01 AI048995
6 · The paper itself

Abstract

backgroundStudies have shown that chronic stress or UV radiation independently suppress immunity. Given their increasing prevalence, it is important to understand whether and how chronic stress and UV radiation may act together to increase susceptibility to disease. Therefore, we investigated potential mediators of a stress-induced increase in emergence and progression of UV-induced squamous cell carcinoma.

methodsSKH1 mice susceptible to UV-induced tumors were unexposed (naïve, n = 4) or exposed (n = 16) to 2240 J/m2 of UVB radiation three times a week for 10 weeks. Half of the UVB-exposed mice were left nonstressed (i.e., they remained in their home cages) and the other half were chronically stressed (i.e., restrained during weeks 4-6). UV-induced tumors were measured weekly from week 11 through week 34, blood was collected at week 34, and tissues were collected at week 35. mRNA expression of interleukin (IL)-12p40, interferon (IFN)-gamma, IL-4, IL-10, CD3epsilon, and CCL27/CTACK, the skin T cell-homing chemokine, in dorsal skin was quantified using real-time polymerase chain reaction. CD4+, CD8+, and CD25+ leukocytes were counted using immunohistochemistry and flow cytometry. All statistical tests were two-sided.

resultsStressed mice had a shorter median time to first tumor (15 versus 16.5 weeks, difference = 1.5 weeks, 95% confidence interval [CI] = -3.0 to 3.3 weeks; P = .03) and reached 50% incidence earlier than controls (15 weeks versus 21 weeks). Stressed mice also had lower IFN-gamma ( mean = 0.03 versus mean = 0.07, difference = 0.04, 95% CI = 0.004 to 0.073; P = .02), CCL27/CTACK (mean = 101 versus mean = 142, difference = 41, 95% CI = 8.1 to 74.4; P = .03), and CD3epsilon (mean = 0.18 versus mean = 0.36, difference = 0.18, 95% CI = 0.06 to 0.30; P = .007) gene expression and lower numbers of infiltrating CD4+ cells (mean = 9.40 versus mean = 13.7, difference = 4.3, 95% CI = 2.36 to 6.32; P = .008) than nonstressed mice. In addition, stressed mice had more regulatory/suppressor CD25+ cells infiltrating tumors and more CD4+ CD25+ cells in circulation (mean = 0.36 versus mean = 0.17, difference = 0.19, 95% CI = 0.005 to 0.38; P = .03) than nonstressed mice.

conclusionsChronic stress increased susceptibility to UV-induced squamous cell carcinoma in this mouse model by suppressing type 1 cytokines and protective T cells and increasing regulatory/suppressor T cell numbers.

Indexed as

AnimalsCarcinoma, Squamous CellCD3 ComplexCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChemokine CCL27Chemokines, CCChronic DiseaseCytokinesDisease Models, AnimalDisease ProgressionFemaleGene Expression Regulation, NeoplasticImmunohistochemistryInterferon-gammaInterleukin-10Ccl27a protein, mouseCD3 ComplexCd3e protein, mouseChemokine CCL27Chemokines, CCCytokinesInterferon-gammaInterleukin-10Interleukin-4Receptors, Interleukin-2

Identifiers

PMID16333031
PMCPMC3422720
OpenAlexW2153507041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.